Thierry Chignon
Chairman at AirInSpace SE
Profile
Thierry Chignon - Managing Partner
Thierry Chignon has over 30 years of experience in Production, Quality Assurance, Quality Control, Regulatory Affairs, Clinical Trials with particular focus on the medical device sector, including a first experience as Head Pharmacist with Institut Mérieux (10 years, now Sanofi Pasteur).
As Managing Director with Quintiles Consulting Europe (now IQVIA), between 1997 and 2006, he defined and participated in the implementation of business development strategies for innovative products in Europe.
Thierry also worked for 5 years as an expert of the Commission of the European Union preparing Guidelines and Regulations for medical devices.
In 2006, Thierry joined Matignon Investissement to raise and deploy the first French fund dedicated to European medical technologies (Matignon Technologies II, €80M), including oversight of 8 investments (50% Growth Capital, 50% Venture Capital).
Thierry joined Mérieux Equity Partners in 2014, as Senior Partner, to launch and manage Mérieux Participations 2 (€150M), then Mérieux Participations 3 (€377M) with several investments in Capital Development and Buyout.
Thierry holds a Degree in Pharmacy, a Master Degree from IEP Paris (Sciences Politiques) and an executive MBA from HEC Paris.
Thierry Chignon active positions
| Companies | Position | Start |
|---|---|---|
AirInSpace SE
 AirInSpace SE Chemicals: SpecialtyProcess Industries AirInSpace SE develops and manufactures medically effective air decontamination systems for hospital, industrial and residential use. It provides solutions for airborne contaminations. The firm's products include Plasmair, Cool Plasmair, Immunair iso, Plasmair C2010, Biocair IF, and Biocair ML. Its services encompass equipment rentals, service contract, control measures, and training. AirInSpace's proprietary technology, Hepa-MD, also provides particle reduction efficiency and microbial destruction. AirInSpace was founded by Laurent Adrien Fullana in 2002 and is headquartered in Elancourt, France. | Chairman | 22/11/2012 |
Mérieux Equity Partners SAS
 Mérieux Equity Partners SAS Investment ManagersFinance Mérieux Equity Partners SAS (Mérieux Equity Partners or MxEP) is a Private Equity and Venture Capital firm, a subsidiary of Mérieux Développement SASU founded in 2009. The firm is headquartered in Lyon, France, with additional offices across the country. | Private Equity Investor | 30/04/2014 |
Seqens SAS
 Seqens SAS Pharmaceuticals: MajorHealth Technology Seqens SASU engages in pharmaceutical and healthcare industries. The company was founded on April 2, 2003 and is headquartered in Ecully, France. | Director/Board Member | - |
Former positions of Thierry Chignon
| Companies | Position | End |
|---|---|---|
| SUPERSONIC IMAGINE | Director/Board Member | 31/07/2019 |
Matignon Investissement et Gestion SAS
 Matignon Investissement et Gestion SAS Investment ManagersFinance Matignon Investissement et Gestion SAS (MIG) is an independent management-owned private equity investment firm based in Paris. MIG was established in 1996 through a management buy-out of Acmer from Banque Worms, formerly part of AXA-UAP and acquired by Deutsche Bank AG in 2001. Following the acquisition, Acmer was delisted. MIG manages private equity and venture capital funds, both generalist and sector specific. | Private Equity Investor | 13/06/2014 |
| NANOBIOTIX | Director/Board Member | - |
| Medicrea SA | Director/Board Member | - |
| VISIOMED GROUP SA | Director/Board Member | - |
Training of Thierry Chignon
| Sciences Po | Masters Business Admin |
| École des Hautes Études Commerciales de Paris | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| VISIOMED GROUP SA | Health Technology |
| NANOBIOTIX | Health Technology |
| Private companies | 7 |
|---|---|
Matignon Investissement et Gestion SAS
Matignon Investissement et Gestion SAS Investment ManagersFinance Matignon Investissement et Gestion SAS (MIG) is an independent management-owned private equity investment firm based in Paris. MIG was established in 1996 through a management buy-out of Acmer from Banque Worms, formerly part of AXA-UAP and acquired by Deutsche Bank AG in 2001. Following the acquisition, Acmer was delisted. MIG manages private equity and venture capital funds, both generalist and sector specific. | Finance |
Arterial Remodelling Technologies SA
 Arterial Remodelling Technologies SA Pharmaceuticals: MajorHealth Technology Arterial Remodelling Technologies SA develops bioresorbable peripheral and coronary polymer stents. Its products includes ART PBS scaffold, procedure and Clinical data. The company was founded by Antoine Lafont, Michel Vert and J. Frederick Cornhill in 2001 and is headquartered in Paris, France. | Health Technology |
AirInSpace SE
AirInSpace SE Chemicals: SpecialtyProcess Industries AirInSpace SE develops and manufactures medically effective air decontamination systems for hospital, industrial and residential use. It provides solutions for airborne contaminations. The firm's products include Plasmair, Cool Plasmair, Immunair iso, Plasmair C2010, Biocair IF, and Biocair ML. Its services encompass equipment rentals, service contract, control measures, and training. AirInSpace's proprietary technology, Hepa-MD, also provides particle reduction efficiency and microbial destruction. AirInSpace was founded by Laurent Adrien Fullana in 2002 and is headquartered in Elancourt, France. | Process Industries |
Mérieux Equity Partners SAS
Mérieux Equity Partners SAS Investment ManagersFinance Mérieux Equity Partners SAS (Mérieux Equity Partners or MxEP) is a Private Equity and Venture Capital firm, a subsidiary of Mérieux Développement SASU founded in 2009. The firm is headquartered in Lyon, France, with additional offices across the country. | Finance |
SuperSonic Imagine SA
 SuperSonic Imagine SA Medical SpecialtiesHealth Technology SuperSonic Imagine SA specializes in ultrasound medical imaging. The company designs, develops and markets a new generation ultrasound system, Aixplorer with an UltraFastTM platform that can acquire images faster than conventional ultrasound systems. Its products are used for general imaging, vascular, hepatology, gastroenterology, and research procedures. It operates under the Aixplorer trademark. SuperSonic Imagine was founded by Jacques Souquet, Armen Sarvazyan, Claude Cohen-Bacrie, Damien Dolimier, Georges Charpak, Jérémy Bercoff, Mickaël Tanter, Mathias Fink and Marianne Leven on March 10, 2005 and is headquartered in Aix-en-Provence, France. | Health Technology |
Seqens SAS
Seqens SAS Pharmaceuticals: MajorHealth Technology Seqens SASU engages in pharmaceutical and healthcare industries. The company was founded on April 2, 2003 and is headquartered in Ecully, France. | Health Technology |
| Medicrea SA | Health Technology |
- Stock Market
- Insiders
- Thierry Chignon
